Granules India532482Pharmaceuticals
USFDA re-inspection began at Granules' Gagillapur facility, which had received a warning letter in 2025
By ScoutQuest · · 1 min read
Heard on business television between 12:12:51 - 12:15:51 IST.
- Re-inspection by USFDA began at the Gagillapur facility, an important plant for Granules.
- The facility had received a warning letter from the USFDA in 2025.
- Re-inspection is seen as important to clear the facility of that warning letter.
- Sources indicated two inspectors are currently inspecting the plant.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Granules India
Granules India Ltd-$: promoter acquires ~2.5 crore warrants
24 Oct 2026
Granules India Ltd-$ promoter buys 9.16% stake, holding rises to 37.39%
24 Oct 2026
Granules India Ltd-$ promoter sells 6.94% stake, holding falls to 31.08%
24 Oct 2026
Source: Live TV News Channel · 19 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.